Key result
In a pilot trial of 30 patients with essential hypertension, acupoint-EECP significantly improved endothelial function (NO, ET-1, and cf-PWV) compared to the control group.
Why the study?
Endothelial function may improve with EECP or acupuncture, motivating this study to evaluate the feasibility of acupoint stimulation combined with EECP for endothelial cell function in essential hypertension.
Does acupoint stimulation combined with enhanced external counterpulsation (EECP) improve endothelial function in patients with essential hypertension?
RCT (n=30)
randomly divided
Does acupoint stimulation combined with enhanced external counterpulsation (EECP) improve endothelial function in patients with essential hypertension?
Acupoint stimulation combined with EECP therapy improves surrogate markers of endothelial function in patients with essential hypertension.
OBJECTIVE: Endothelial function may improve with enhanced external counterpulsation (EECP) or acupuncture. This study aimed to evaluate the feasibility of acupoint stimulation combined with EECP (acupoint-EECP) for endothelial cell function in patients with essential hypertension. METHODS: Thirty essential hypertensive patients were, randomly divided into two groups, with 15 patients in the acupoint-EECP group, and 15 patients in the control group, of which 3 cases were lost by week 6. Both groups were treated with continued medicine. The participants in the acupoint-EECP group received acupoint stimulation combined with EECP therapy, 45 min for each time, 5 times weekly for 6 weeks for a total of 22.5 hours. The selected acupoints are Zusanli (ST36), Fenglong (ST40) and Sanyinjiao (SP6). The curative effects of the two groups were compared. RESULTS: The acupoint-EECP group (n=15) showed significant improvement in endothelial function [nitric oxide (NO) ,endothelin-1 (ET-1) and carotid-femoral pulse wave velocity (cf-PWV), respectively] values compared to the control group (n=12). Multiple imputation (n = 20 imputations) was performed to account for potential bias due to missing data. In stratified analyses, SBP and DBP values decreased when the baseline SBP was ≥120 mmHg and DBP was ≥80 mmHg. CONCLUSIONS: These findings suggest the feasibility of acupoint-EECP in improving endothelial function and treating hypertension. (The Chinese clinical trial registration number is ChiCTR2100053795.).
No takes yet. Share an insight, caveat, or question.
Lin et al. (2023) conducted an RCT in essential hypertension (n=30). acupoint stimulation combined with enhanced external counterpulsation (acupoint-EECP) vs. control group (continued medicine) was evaluated on endothelial function (nitric oxide, endothelin-1, and carotid-femoral pulse wave velocity). In a pilot trial of 30 patients with essential hypertension, acupoint-EECP significantly improved endothelial function (NO, ET-1, and cf-PWV) compared to the control group.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: